These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 28600569

  • 21. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
    Prevete N, Liotti F, Visciano C, Marone G, Melillo RM, de Paulis A.
    Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
    [Abstract] [Full Text] [Related]

  • 22. The role of MALAT-1 in the invasion and metastasis of gastric cancer.
    Chen D, Liu L, Wang K, Yu H, Wang Y, Liu J, Guo Y, Zhang H.
    Scand J Gastroenterol; 2017 Jul; 52(6-7):790-796. PubMed ID: 28276823
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1.
    Mei JW, Yang ZY, Xiang HG, Bao R, Ye YY, Ren T, Wang XF, Shu YJ.
    BMC Cancer; 2019 Jul 29; 19(1):740. PubMed ID: 31357957
    [Abstract] [Full Text] [Related]

  • 24. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L, Liu JY, Shi Y, Tang B, He T, Liu JJ, Fan JY, Wu B, Xu XH, Zhao YL, Qian F, Cui YH, Yu PW.
    J Exp Clin Cancer Res; 2019 May 21; 38(1):206. PubMed ID: 31113461
    [Abstract] [Full Text] [Related]

  • 25. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H, Sun JD, Yan LJ, Zhao XP.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):845-51. PubMed ID: 27507215
    [Abstract] [Full Text] [Related]

  • 26. FPR2 enhances colorectal cancer progression by promoting EMT process.
    Lu J, Zhao J, Jia C, Zhou L, Cai Y, Ni J, Ma J, Zheng M, Lu A.
    Neoplasma; 2019 Sep 16; 66(5):785-791. PubMed ID: 31288528
    [Abstract] [Full Text] [Related]

  • 27. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells.
    Dai YH, Tang YP, Zhu HY, Lv L, Chu Y, Zhou YQ, Huo JR.
    Dig Dis Sci; 2012 May 16; 57(5):1253-60. PubMed ID: 22350782
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1.
    Hu L, Wu H, Wan X, Liu L, He Y, Zhu L, Liu S, Yao H, Zhu Z.
    Biochem Biophys Res Commun; 2018 Apr 30; 499(1):52-58. PubMed ID: 29550487
    [Abstract] [Full Text] [Related]

  • 29. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
    Zhang J, Liu Y, Zhang J, Cui X, Li G, Wang J, Ren H, Zhang Y.
    Oncol Rep; 2016 Jun 30; 35(6):3607-13. PubMed ID: 27109028
    [Abstract] [Full Text] [Related]

  • 30. FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization.
    Xie X, He J, Wang Q, Liu Y, Chen W, Shi K.
    J Ovarian Res; 2021 Dec 20; 14(1):177. PubMed ID: 34930387
    [Abstract] [Full Text] [Related]

  • 31. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
    Jiang Z, Wang X, Li J, Yang H, Lin X.
    J Cell Mol Med; 2018 Sep 20; 22(9):4377-4386. PubMed ID: 29992789
    [Abstract] [Full Text] [Related]

  • 32. A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression.
    Lei L, Hong LL, Ling ZN, Zhong Y, Hu XY, Li P, Ling ZQ.
    Clin Transl Gastroenterol; 2021 Jul 01; 12(7):e00377. PubMed ID: 34193800
    [Abstract] [Full Text] [Related]

  • 33. Circ_0009910 regulates growth and metastasis and is associated with poor prognosis in gastric cancer.
    Liu M, Liu KD, Zhang L, Cai J, Yao HW, Bai YK, Zhang ZT.
    Eur Rev Med Pharmacol Sci; 2018 Dec 01; 22(23):8248-8256. PubMed ID: 30556864
    [Abstract] [Full Text] [Related]

  • 34. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
    Zhao W, Jia L, Kuai X, Tang Q, Huang X, Yang T, Qiu Z, Zhu J, Huang J, Huang W, Feng Z.
    Cancer Med; 2019 Mar 01; 8(3):1135-1147. PubMed ID: 30632714
    [Abstract] [Full Text] [Related]

  • 35. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
    Hou XM, Yuan SQ, Zhao D, Liu XJ, Wu XA.
    Biosci Rep; 2019 Jan 31; 39(1):. PubMed ID: 30509961
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
    Chen X, Huang Y, Wang Y, Wu Q, Hong S, Huang Z.
    J Physiol Biochem; 2019 Feb 31; 75(1):117-123. PubMed ID: 30746617
    [Abstract] [Full Text] [Related]

  • 38. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B, Chen Q, Cao Y, Ma X, Yin C, Jia Y, Zang A, Fan W.
    PLoS One; 2016 Feb 31; 11(12):e0168904. PubMed ID: 28033430
    [Abstract] [Full Text] [Related]

  • 39. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ, Dai FX, Long ZW, Cai H, Liu XW, Zhou Y, Hong Q, Dong QZ, Wang YN, Huang H.
    Oncol Rep; 2017 Jun 31; 37(6):3279-3286. PubMed ID: 28440473
    [Abstract] [Full Text] [Related]

  • 40. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
    Lee HJ, Park MK, Lee EJ, Lee CH.
    Int J Biochem Cell Biol; 2013 Dec 31; 45(12):2801-7. PubMed ID: 24120851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.